@article{4ca9da31ddb143918f4c2062a75704e9,
title = "Adhesio interthalamica in individuals at high-risk for developing psychosis and patients with psychotic disorders",
abstract = "Abnormal neurodevelopment in midline structures such as the adhesio interthalamica (AI) has been reported in psychotic disorders, but it is unknown whether individuals at risk for the disorder share the AI findings observed in patients with florid psychosis. Magnetic resonance imaging of 162 patients with first-episode psychosis (FEP), 89 patients with chronic schizophrenia, 135 individuals at ultra high-risk (UHR) of psychosis (of whom 39 later developed psychosis), and 87 healthy controls were used to investigate the length and prevalence of the AI. The relation of the AI length to lateral ventricular enlargement was also explored. The patients with FEP and chronic schizophrenia as well as UHR individuals had a shorter AI than the controls, but there was no difference in the AI findings between the UHR individuals who did and did not subsequently develop psychosis. There was a negative correlation between the AI length and lateral ventricular volume in all the diagnostic groups. The absence of the AI was more common in the chronic schizophrenia patients when compared with all other groups. These results support the notion that the AI absence or shorter length could be a neurodevelopmental marker related to vulnerability to psychopathology, but also suggest that schizophrenia patients may manifest progressive brain changes related to ongoing atrophy of the AI after the onset.",
keywords = "Adhesio interthalamica, High-risk, Lateral ventricles, Neurodevelopment, Schizophrenia",
author = "Tsutomu Takahashi and Murat Y{\"u}cel and Yung, {Alison R.} and Wood, {Stephen J.} and Phillips, {Lisa J.} and Berger, {Gregor E.} and Anthony Ang and Bridget Soulsby and McGorry, {Patrick D.} and Michio Suzuki and Dennis Velakoulis and Christos Pantelis",
note = "Funding Information: This study was supported by project grants from the National Health & Medical Research Council (NHMRC; grant IDs: 145627, 145737, 970598, 981112, 970391), NHMRC Program Grant (ID: 350241), and the Colonial Foundation. Drs. Velakoulis and Wood were supported as Research Officers with funding from the NHMRC. Dr. McGorry was supported by a NARSAD Distinguished Investigator Award. Dr. Wood is currently supported by a Clinical Career Development Award from the NHMRC (ID: 359223) and a NARSAD Young Investigator Award. Dr. Y{\"u}cel was supported by a NHMRC Clinical Career Development Award (ID: 509345). Dr. Takahashi was supported to undertake this work by a Grant-in-Aid for Scientific Research (No. 19591346) from the Japanese Society for the Promotion of Science, and a Research Grant (17-2, 18-6) for Nervous and Mental Disorders from the Ministry of Health and Welfare, Japan. Dr. Takahashi was supported by a Program for Promoting Internationalization of University Education from the Ministry of Education, Culture, Sports, Science and Technology, Japan. ",
year = "2008",
month = oct,
day = "1",
doi = "10.1016/j.pnpbp.2008.07.007",
language = "英語",
volume = "32",
pages = "1708--1714",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "7",
}